Roberts Glore & Co »

Halozyme Therapeutics shares owned by Roberts Glore & Co

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Roberts Glore & Co from 13F filings

Historical chart of Roberts Glore & Co investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Roberts Glore & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Roberts Glore & Co

Quarter filed Position value Share count Share price at filing
2026-06-30 $202k 2.6k 78.27

More positions owned by Roberts Glore & Co

Berkshire Hathaway Inc Del Cl B New (BRK.B)
Apple (AAPL)
Alphabet Cap Stk Cl C (GOOG)
Microsoft Corporation (MSFT)
Johnson & Johnson (JNJ)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Malvern Fds Strm Infproidx (VTIP)
Vanguard Index Fds Total Stk Mkt (VTI)
Abbvie (ABBV)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
Amazon (AMZN)
Cisco Systems (CSCO)
NVIDIA Corporation (NVDA)
Sprott Asset Management Physical Gold An (CEF)
Abbott Laboratories (ABT)

View all positions for Roberts Glore & Co

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Capital Management
Vanguard Portfolio Management
State Street Corporation
Invesco
Robeco Investment Management
Bank of America Corporation
Morgan Stanley
Geode Capital Management
William Blair Investment Management
Snyder Capital Management
Dimensional Fund Advisors
D. E. Shaw & Co
Thomas Stevens, CFA"
Royal London Asset Management

View all funds holding Halozyme Therapeutics